Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1Phase 1/2 1

Status

Completed 5Unknown 3

Sponsor Class

INDUSTRY 7OTHER 1

Study Type

Observational 5Interventional 3

Sponsor

Conditions

Breast Neoplasms 13138Neoplasms 10481Carcinoma, Non-Small-Cell Lung 6874Prostatic Neoplasms 6268Colorectal Neoplasms 5948Lung Neoplasms 5105Multiple Myeloma 3577Pancreatic Neoplasms 3563Leukemia, Myeloid, Acute 3510Neoplasm Metastasis 3508Carcinoma, Hepatocellular 3273Ovarian Neoplasms 3168Melanoma 3141Stomach Neoplasms 3057Lymphoma 2983Head and Neck Neoplasms 2604Recurrence 2557Precursor Cell Lymphoblastic Leukemia-Lymphoma 2499Leukemia 2362Colonic Neoplasms 2328Brain Neoplasms 2313Lymphoma, Non-Hodgkin 2269Rectal Neoplasms 2192Uterine Cervical Neoplasms 2191Glioblastoma 2016Leukemia, Lymphocytic, Chronic, B-Cell 1992Carcinoma, Renal Cell 1913Squamous Cell Carcinoma of Head and Neck 1880Lymphoma, Follicular 1848Esophageal Neoplasms 1801

Interventions

Fentanyl 3Nasal Sprays 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

8 trials
RecentStart dateEnrollment
Breakthrough Cancer Pain × Clear all
NCT05531422 2024-06-12

Effectiveness and Tolerance of Inhaled Fentanyl Aerosol (25µg/Dose) in Chinese Patients With BTcP

Lee's Pharmaceutical Limited

Phase 2 Completed
60 enrolled

Breakthrough Cancer Pain

NCT03895762 2022-05-05

OASIS

A.Menarini Asia-Pacific Holdings Pte Ltd

Completed
143 enrolled

Breakthrough Cancer Pain

NCT04713189 2021-02-02

Effectiveness and Tolerance of Inhaled Fentanyl Aerosol (25µg/Dose) in Chinese Patients With Breakthrough Cancer Pain

Lee's Pharmaceutical Limited

Phase 1/2 Unknown
96 enrolled

Breakthrough Cancer Pain

NCT02899884 2019-11-22

Characterisation and Epidemiology of Breakthrough Cancer Pain in Spain

Takeda

Completed
3,765 enrolled 10 charts

Breakthrough Cancer Pain

NCT03669263 2018-09-13

A Dose Titration Study of Fentanyl Buccal Soluble Film for Breakthrough Cancer Pain in Taiwan

Chang Gung Memorial Hospital

Phase NA Completed
36 enrolled

Breakthrough Cancer Pain

NCT01693328 2014-01-15

Qualipec

Archimedes Development Ltd

Unknown
300 enrolled

Breakthrough Cancer Pain

NCT01698645 2013-07-11

Qualipec

Archimedes Development Ltd

Unknown
150 enrolled

Breakthrough Cancer Pain

NCT01045603 2012-10-29

INIS

Takeda

Completed
309 enrolled

Breakthrough Cancer Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡